Laurent Brossay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Laurent Brossay has a total of 361 co-authors. Here are the top co-authors by number of shared publications:
- Mitchell Kronenberg
Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA
9 shared publications Nicolas Burdin
La Jolla Institute of Allergy and Immunology, 10355 Science Center Drive, San Diego CA 92121, USA
9 shared publicationsMitchell Kronenberg
Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology , San Diego, CA 92121
8 shared publications- Samantha M. Borys
Brown University
8 shared publications Scott H. Robbins
§Division of Biology and Medicine, Department of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912
8 shared publicationsMarlowe S. Tessmer
Department of Molecular Microbiology and Immunology, Division of Biology and Medicine, Brown University , Providence, RI 02912
7 shared publications
Latest Publications
- Open Access
- 17 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 9839
PD-1 regulates CD4+ T cell-mediated CD8+ T cell responses in the brain to balance viral control and neuroinflammation
Programmed cell death protein 1 (PD-1) is expressed by T cells during progressive multifocal leukoencephalopathy (PML), a life-threatening brain disease caused by the human-only JC polyomavirus (JCPyV). PD-1 checkpoint immunotherapy has benefited some PML patients, but reasons for its variable outcomes are unclear. Using mouse polyomavirus (MuPyV), we show that PD-1 loss acts in a brain-autonomous manner to increase the magnitude of brain-infiltrating CD4+ and CD8+ T cells and the function of virus-specific CD8+ T cells; in concert, brain virus levels decline and neuroinflammation increases. Deletion of PD-1 in CD4+ T cells, but not CD8+ T cells, recapitulates effects of global PD-1 loss. Single-cell RNA sequencing shows that PD-1-deficient CD8+ T cells cluster as effectors while transcripts associated with proliferation and function are upregulated with loss of PD-1. Thus, CD4+ T cell-intrinsic PD-1 signaling balances antiviral defense against neural injury during polyomavirus infection of the brain.
- 17 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 9839
Open AccessPD-1 regulates CD4+ T cell-mediated CD8+ T cell responses in the brain to balance viral control and neuroinflammation
Programmed cell death protein 1 (PD-1) is expressed by T cells during progressive multifocal leukoencephalopathy (PML), a life-threatening brain disease caused by the human-only JC polyomavirus (JCPyV). PD-1 checkpoint immunotherapy has benefited some PML patients, but reasons for its variable outcomes are unclear. Using mouse polyomavirus (MuPyV), we show that PD-1 loss acts in a brain-autonomous manner to increase the magnitude of brain-infiltrating CD4+ and CD8+ T cells and the function of virus-specific CD8+ T cells; in concert, brain virus levels decline and neuroinflammation increases. Deletion of PD-1 in CD4+ T cells, but not CD8+ T cells, recapitulates effects of global PD-1 loss. Single-cell RNA sequencing shows that PD-1-deficient CD8+ T cells cluster as effectors while transcripts associated with proliferation and function are upregulated with loss of PD-1. Thus, CD4+ T cell-intrinsic PD-1 signaling balances antiviral defense against neural injury during polyomavirus infection of the brain.
- Open Access
- 15 April 2026
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 215 (4)
E-cadherin expression promotes tumor growth via KLRG1-dependent pathways
Transformed cells frequently adapt to immune pressure by modulating expression of ligands for PD-1 and CTLA-4. Despite the success of therapies targeting these interactions, only a minority of patients experience a clinical response, highlighting the critical need for alternative targets. Prior work from our group showed that the inhibitory receptor KLRG1 binds to tumor-derived E-cadherin. However, the therapeutic potential of targeting KLRG1 signaling remains incompletely understood. To address this, we generated a library of cancer cell lines engineered to express varying levels of E-cadherin. Across multiple models, we demonstrate that E-cadherin expression renders tumors more aggressive in vivo. Using an RMA-S cell line possessing a mutated E-cadherin that abrogates KLRG1 binding while preserving cadherin homotypic interactions, we demonstrate that the protumor effect of E-cadherin expression is largely mediated by KLRG1. To further dissect the cellular targets of KLRG1 signaling, we generated KLRG1fl/fl mice and performed lineage-specific deletion. Surprisingly, we discovered that KLRG1 expression on CD8+ T cells, rather than on natural killer cells, impairs the immune control of B16-F10 E-cadherin+ tumors. Taken together, these results reveal an underappreciated protumor role for E-cadherin and highlight KLRG1 as a promising target for future checkpoint blockade strategies, particularly in tumors retaining epithelial features.
- 15 April 2026
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 215 (4)
Open AccessE-cadherin expression promotes tumor growth via KLRG1-dependent pathways
Transformed cells frequently adapt to immune pressure by modulating expression of ligands for PD-1 and CTLA-4. Despite the success of therapies targeting these interactions, only a minority of patients experience a clinical response, highlighting the critical need for alternative targets. Prior work from our group showed that the inhibitory receptor KLRG1 binds to tumor-derived E-cadherin. However, the therapeutic potential of targeting KLRG1 signaling remains incompletely understood. To address this, we generated a library of cancer cell lines engineered to express varying levels of E-cadherin. Across multiple models, we demonstrate that E-cadherin expression renders tumors more aggressive in vivo. Using an RMA-S cell line possessing a mutated E-cadherin that abrogates KLRG1 binding while preserving cadherin homotypic interactions, we demonstrate that the protumor effect of E-cadherin expression is largely mediated by KLRG1. To further dissect the cellular targets of KLRG1 signaling, we generated KLRG1fl/fl mice and performed lineage-specific deletion. Surprisingly, we discovered that KLRG1 expression on CD8+ T cells, rather than on natural killer cells, impairs the immune control of B16-F10 E-cadherin+ tumors. Taken together, these results reveal an underappreciated protumor role for E-cadherin and highlight KLRG1 as a promising target for future checkpoint blockade strategies, particularly in tumors retaining epithelial features.
- Open Access
immgenT Treg: A Reference Landscape of Regulatory T Cell States in Mice
CD4 Foxp3 regulatory T cells (Tregs) are central to immunity, tolerance, and tissue homeostasis, yet their extensive heterogeneity lacks a unifying framework. Within the immgenT project, we profiled gene expression, surface markers and TCR clonotypes of mouse Tregs. Using a joint RNA–protein deep generative model, we define the Treg landscape, organized around eight conserved clusters shared across tissues and conditions, with immune context reshaping their relative abundance rather than generating new states, including a prominent circulating effector Treg population enriched in select non-lymphoid tissues. We validate this framework by integrating external datasets from conditions not represented in immgenT and by defining a flow cytometry panel spanning the Treg landscape. Together, immgenT provides a scalable, reusable reference that unifies Treg heterogeneity across tissues and immune challenges.
Open AccessimmgenT Treg: A Reference Landscape of Regulatory T Cell States in Mice
CD4 Foxp3 regulatory T cells (Tregs) are central to immunity, tolerance, and tissue homeostasis, yet their extensive heterogeneity lacks a unifying framework. Within the immgenT project, we profiled gene expression, surface markers and TCR clonotypes of mouse Tregs. Using a joint RNA–protein deep generative model, we define the Treg landscape, organized around eight conserved clusters shared across tissues and conditions, with immune context reshaping their relative abundance rather than generating new states, including a prominent circulating effector Treg population enriched in select non-lymphoid tissues. We validate this framework by integrating external datasets from conditions not represented in immgenT and by defining a flow cytometry panel spanning the Treg landscape. Together, immgenT provides a scalable, reusable reference that unifies Treg heterogeneity across tissues and immune challenges.
- Open Access
- 19 December 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (51) , eaea8707
Unconventional CD8 + T cell surveillance of cytomegalovirus via Qa-1/HLA-E–restricted epitope recognition
Nonclassical CD8 + T cells can compensate for classical CD8 + T cell effector responses during murine cytomegalovirus (MCMV) infection. Through a combination of motif-based discovery, predictive algorithms, AlphaFold3 structural modeling, and biological assays, we identified multiple MCMV and human cytomegalovirus (HCMV) peptides that bind to Qa-1 and HLA-E, respectively. In the mouse system, we demonstrated that these virally encoded antigens stimulate Qa-1–restricted CD8 + T cells ex vivo, which can be tracked using MCMV peptide–loaded Qa-1 tetramers. Adoptive transfer of predominantly Qa-1 tetramer + CD8 + T cells into RAG-1–deficient mice protects them from mortality, underscoring the critical role of these cells in host defense. Single-cell RNA (scRNA)/TotalSeq and single-cell T cell receptor sequencing (scTCR-seq) reveal the expansion of unique TCR αβ clonotypes, indicating convergent antigen specificity. Together, our findings uncover a conserved and functionally important nonclassical CD8 + T cell axis mediated by Qa-1/HLA-E modulating adaptive immunity independent of classical major histocompatibility complex class I (MHC-I) pathways and present previously unidentified opportunities for vaccine development.
- 19 December 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (51) , eaea8707
Open AccessUnconventional CD8 + T cell surveillance of cytomegalovirus via Qa-1/HLA-E–restricted epitope recognition
Nonclassical CD8 + T cells can compensate for classical CD8 + T cell effector responses during murine cytomegalovirus (MCMV) infection. Through a combination of motif-based discovery, predictive algorithms, AlphaFold3 structural modeling, and biological assays, we identified multiple MCMV and human cytomegalovirus (HCMV) peptides that bind to Qa-1 and HLA-E, respectively. In the mouse system, we demonstrated that these virally encoded antigens stimulate Qa-1–restricted CD8 + T cells ex vivo, which can be tracked using MCMV peptide–loaded Qa-1 tetramers. Adoptive transfer of predominantly Qa-1 tetramer + CD8 + T cells into RAG-1–deficient mice protects them from mortality, underscoring the critical role of these cells in host defense. Single-cell RNA (scRNA)/TotalSeq and single-cell T cell receptor sequencing (scTCR-seq) reveal the expansion of unique TCR αβ clonotypes, indicating convergent antigen specificity. Together, our findings uncover a conserved and functionally important nonclassical CD8 + T cell axis mediated by Qa-1/HLA-E modulating adaptive immunity independent of classical major histocompatibility complex class I (MHC-I) pathways and present previously unidentified opportunities for vaccine development.
- Open Access
- 12 December 2025
- Published by Springer Nature in Research Square
PD-1 regulates CD4+ T cell-mediated CD8+ T cell responses in the brain to balance viral control and neuroinflammation
Programmed cell death protein 1 (PD-1) is expressed by T cells during progressive multifocal leukoencephalopathy (PML), a life-threatening brain disease caused by the human-only JC polyomavirus. Why PD-1 blockade finds variable success in PML patients is unclear. Brain CD4+ and CD8+ T cells are PD-1high during mouse polyomavirus (MuPyV) encephalitis. Here, we show that PD-1 loss during MuPyV infection acts in a brain-autonomous manner to increase the magnitude of brain-infiltrating CD4+ and CD8+ T cells and the function of virus-specific CD8+ T cells; in concert, brain virus levels decline and neuroinflammation increases. Deletion of PD-1 in CD4+ T cells, but not CD8+ T cells, recapitulates effects of global PD-1 loss. Single-cell RNA sequencing shows that PD-1-deficient CD8+ T cells cluster as effectors while transcripts associated with proliferation and function are upregulated with loss of PD-1. Thus, CD4+ T cell-intrinsic PD-1 signaling balances antiviral defense against neural injury during polyomavirus CNS infection.
- 12 December 2025
- Published by Springer Nature in Research Square
Open AccessPD-1 regulates CD4+ T cell-mediated CD8+ T cell responses in the brain to balance viral control and neuroinflammation
Programmed cell death protein 1 (PD-1) is expressed by T cells during progressive multifocal leukoencephalopathy (PML), a life-threatening brain disease caused by the human-only JC polyomavirus. Why PD-1 blockade finds variable success in PML patients is unclear. Brain CD4+ and CD8+ T cells are PD-1high during mouse polyomavirus (MuPyV) encephalitis. Here, we show that PD-1 loss during MuPyV infection acts in a brain-autonomous manner to increase the magnitude of brain-infiltrating CD4+ and CD8+ T cells and the function of virus-specific CD8+ T cells; in concert, brain virus levels decline and neuroinflammation increases. Deletion of PD-1 in CD4+ T cells, but not CD8+ T cells, recapitulates effects of global PD-1 loss. Single-cell RNA sequencing shows that PD-1-deficient CD8+ T cells cluster as effectors while transcripts associated with proliferation and function are upregulated with loss of PD-1. Thus, CD4+ T cell-intrinsic PD-1 signaling balances antiviral defense against neural injury during polyomavirus CNS infection.
- Open Access
PD-1 regulates CD4 + T cell-mediated CD8 + T cell responses in the brain to balance viral control and neuroinflammation
Programmed cell death protein 1 (PD-1) is expressed by T cells during progressive multifocal leukoencephalopathy (PML), a life-threatening brain disease caused by the human-only JC polyomavirus. Why PD-1 blockade finds variable success in PML patients is unclear. Brain CD4 + and CD8 + T cells are PD-1 high during mouse polyomavirus (MuPyV) encephalitis. Here, we show that PD-1 loss during MuPyV infection acts in a brain-autonomous manner to increase the magnitude of brain-infiltrating CD4 + and CD8 + T cells and the function of virus-specific CD8 + T cells; in concert, brain virus levels decline and neuroinflammation increases. Deletion of PD-1 in CD4 + T cells, but not CD8 + T cells, recapitulates effects of global PD-1 loss. Single-cell RNA sequencing shows that PD-1-deficient CD8 + T cells cluster as effectors while transcripts associated with proliferation and function are upregulated with loss of PD-1. Thus, CD4 + T cell-intrinsic PD-1 signaling balances antiviral defense against neural injury during polyomavirus CNS infection.
Open AccessPD-1 regulates CD4 + T cell-mediated CD8 + T cell responses in the brain to balance viral control and neuroinflammation
Programmed cell death protein 1 (PD-1) is expressed by T cells during progressive multifocal leukoencephalopathy (PML), a life-threatening brain disease caused by the human-only JC polyomavirus. Why PD-1 blockade finds variable success in PML patients is unclear. Brain CD4 + and CD8 + T cells are PD-1 high during mouse polyomavirus (MuPyV) encephalitis. Here, we show that PD-1 loss during MuPyV infection acts in a brain-autonomous manner to increase the magnitude of brain-infiltrating CD4 + and CD8 + T cells and the function of virus-specific CD8 + T cells; in concert, brain virus levels decline and neuroinflammation increases. Deletion of PD-1 in CD4 + T cells, but not CD8 + T cells, recapitulates effects of global PD-1 loss. Single-cell RNA sequencing shows that PD-1-deficient CD8 + T cells cluster as effectors while transcripts associated with proliferation and function are upregulated with loss of PD-1. Thus, CD4 + T cell-intrinsic PD-1 signaling balances antiviral defense against neural injury during polyomavirus CNS infection.
- 2 April 2025
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 214 (6) , 1310-1320
Lung NK cells are sufficient to control viral dissemination during respiratory MCMV infection
Murine cytomegalovirus (MCMV) respiratory dissemination schemes, which mimic natural infection routes, have only recently become an area of investigation. Using an intratracheal (i.t.) infection method, we discovered that the respiratory infection route yields differential infection kinetics compared to the widely used intraperitoneal (i.p.) infection method. Remarkably, we find that respiratory infection results in limited dissemination, with the virus being mostly contained in the pulmonary tissue. Importantly, using Rag1, Ly49H, and natural killer (NK) cell-deficient animals, we find that lung conventional NK (cNK) cells play a critical role in preventing MCMV-induced morbidity. Mechanistically, we show that indirect activation of lung NK cells via interleukin (IL)-12 and type 1 interferon (IFN) inflammatory cytokines is dispensable, while direct activation via Ly49H is essential in preventing morbidity from i.t. infection. Additionally, we did not find a significant role for ILC2 or tissue-resident NK (trNK) cells in the prevention of viral dissemination, and we did not observe an increase in the abundance of these cells. These findings uncover an unanticipated role for pulmonary cNK cells in preventing viral dissemination from infected lungs.
- 2 April 2025
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 214 (6) , 1310-1320
Lung NK cells are sufficient to control viral dissemination during respiratory MCMV infection
Murine cytomegalovirus (MCMV) respiratory dissemination schemes, which mimic natural infection routes, have only recently become an area of investigation. Using an intratracheal (i.t.) infection method, we discovered that the respiratory infection route yields differential infection kinetics compared to the widely used intraperitoneal (i.p.) infection method. Remarkably, we find that respiratory infection results in limited dissemination, with the virus being mostly contained in the pulmonary tissue. Importantly, using Rag1, Ly49H, and natural killer (NK) cell-deficient animals, we find that lung conventional NK (cNK) cells play a critical role in preventing MCMV-induced morbidity. Mechanistically, we show that indirect activation of lung NK cells via interleukin (IL)-12 and type 1 interferon (IFN) inflammatory cytokines is dispensable, while direct activation via Ly49H is essential in preventing morbidity from i.t. infection. Additionally, we did not find a significant role for ILC2 or tissue-resident NK (trNK) cells in the prevention of viral dissemination, and we did not observe an increase in the abundance of these cells. These findings uncover an unanticipated role for pulmonary cNK cells in preventing viral dissemination from infected lungs.
- 3 January 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (3)
Tissue-resident NK cells do their own glandscaping
In this issue of JEM, Sparano et al. (https://doi.org/10.1084/jem.20240930) present compelling evidence that salivary gland trNK cells originate from cNK cells and are developmentally distinct from ILC1 cells. Mechanistically, they demonstrate that continuous autocrine TGF-β signaling drives salivary gland tissue residency and works in synergy with IL-15 to enhance Hobit-dependent cytotoxicity.
- 3 January 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (3)
Tissue-resident NK cells do their own glandscaping
In this issue of JEM, Sparano et al. (https://doi.org/10.1084/jem.20240930) present compelling evidence that salivary gland trNK cells originate from cNK cells and are developmentally distinct from ILC1 cells. Mechanistically, they demonstrate that continuous autocrine TGF-β signaling drives salivary gland tissue residency and works in synergy with IL-15 to enhance Hobit-dependent cytotoxicity.
- 20 December 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 9 (102) , eadl2967
NK cells restrain cytotoxic CD8 + T cells in the submandibular gland via PD-1–PD-L1
The increasing use of anti–programmed cell death 1 (PD-1) immune checkpoint blockade has led to the emergence of immune-related adverse events (irAEs), including dysfunction of the submandibular gland (SMG). In this study, we investigated the immunoregulatory mechanism contributing to the susceptibility of the SMG to irAEs. We found that the SMGs of PD-1–deficient mice and anti–programmed cell death ligand 1 (PD-L1)–treated mice harbor an expanded population of CD8 + T cells. We demonstrate that natural killer (NK) cells expressing PD-L1 tightly regulate CD8 + T cells in the SMG. When this immunoregulation is disrupted, CD8 + T cells clonally expand and acquire a unique transcriptional profile consistent with T cell receptor (TCR) activation. These clonally expanded cells phenotypically overlapped with cytotoxic GzmK + CD8 + T autoimmune cells identified in patients with primary Sjögren’s syndrome. Understanding how NK cells modulate CD8 + T cell activity in the SMG opens new avenues for preventing irAEs in patients undergoing checkpoint blockade therapies.
- 20 December 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 9 (102) , eadl2967
NK cells restrain cytotoxic CD8 + T cells in the submandibular gland via PD-1–PD-L1
The increasing use of anti–programmed cell death 1 (PD-1) immune checkpoint blockade has led to the emergence of immune-related adverse events (irAEs), including dysfunction of the submandibular gland (SMG). In this study, we investigated the immunoregulatory mechanism contributing to the susceptibility of the SMG to irAEs. We found that the SMGs of PD-1–deficient mice and anti–programmed cell death ligand 1 (PD-L1)–treated mice harbor an expanded population of CD8 + T cells. We demonstrate that natural killer (NK) cells expressing PD-L1 tightly regulate CD8 + T cells in the SMG. When this immunoregulation is disrupted, CD8 + T cells clonally expand and acquire a unique transcriptional profile consistent with T cell receptor (TCR) activation. These clonally expanded cells phenotypically overlapped with cytotoxic GzmK + CD8 + T autoimmune cells identified in patients with primary Sjögren’s syndrome. Understanding how NK cells modulate CD8 + T cell activity in the SMG opens new avenues for preventing irAEs in patients undergoing checkpoint blockade therapies.
- 12 October 2023
- Published by Springer Nature in Nature Immunology
- Vol. 24 (11) , 1933-1946
Cryptic MHC-E epitope from influenza elicits a potent cytolytic T cell response
The extent to which unconventional forms of antigen presentation drive T cell immunity is unknown. By convention, CD8 T cells recognize viral peptides, or epitopes, in association with classical major histocompatibility complex (MHC) class I, or MHC-Ia, but immune surveillance can, in some cases, be directed against peptides presented by nonclassical MHC-Ib, in particular the MHC-E proteins (Qa-1 in mice and HLA-E in humans); however, the overall importance of nonclassical responses in antiviral immunity remains unclear. Similarly uncertain is the importance of ‘cryptic’ viral epitopes, defined as those undetectable by conventional mapping techniques. Here we used an immunopeptidomic approach to search for unconventional epitopes that drive T cell responses in mice infected with influenza virus A/Puerto Rico/8/1934. We identified a nine amino acid epitope, termed M-SL9, that drives a co-immunodominant, cytolytic CD8 T cell response that is unconventional in two major ways: first, it is presented by Qa-1, and second, it has a cryptic origin, mapping to an unannotated alternative reading frame product of the influenza matrix gene segment. Presentation and immunogenicity of M-SL9 are dependent on the second AUG codon of the positive sense matrix RNA segment, suggesting translation initiation by leaky ribosomal scanning. During influenza virus A/Puerto Rico/8/1934 infection, M-SL9-specific T cells exhibit a low level of egress from the lungs and strong differentiation into tissue-resident memory cells. Importantly, we show that M-SL9/Qa-1-specific T cells can be strongly induced by messenger RNA vaccination and that they can mediate antigen-specific cytolysis in vivo. Our results demonstrate that noncanonical translation products can account for an important fraction of the T cell repertoire and add to a growing body of evidence that MHC-E-restricted T cells could have substantial therapeutic value.
- 12 October 2023
- Published by Springer Nature in Nature Immunology
- Vol. 24 (11) , 1933-1946
Cryptic MHC-E epitope from influenza elicits a potent cytolytic T cell response
The extent to which unconventional forms of antigen presentation drive T cell immunity is unknown. By convention, CD8 T cells recognize viral peptides, or epitopes, in association with classical major histocompatibility complex (MHC) class I, or MHC-Ia, but immune surveillance can, in some cases, be directed against peptides presented by nonclassical MHC-Ib, in particular the MHC-E proteins (Qa-1 in mice and HLA-E in humans); however, the overall importance of nonclassical responses in antiviral immunity remains unclear. Similarly uncertain is the importance of ‘cryptic’ viral epitopes, defined as those undetectable by conventional mapping techniques. Here we used an immunopeptidomic approach to search for unconventional epitopes that drive T cell responses in mice infected with influenza virus A/Puerto Rico/8/1934. We identified a nine amino acid epitope, termed M-SL9, that drives a co-immunodominant, cytolytic CD8 T cell response that is unconventional in two major ways: first, it is presented by Qa-1, and second, it has a cryptic origin, mapping to an unannotated alternative reading frame product of the influenza matrix gene segment. Presentation and immunogenicity of M-SL9 are dependent on the second AUG codon of the positive sense matrix RNA segment, suggesting translation initiation by leaky ribosomal scanning. During influenza virus A/Puerto Rico/8/1934 infection, M-SL9-specific T cells exhibit a low level of egress from the lungs and strong differentiation into tissue-resident memory cells. Importantly, we show that M-SL9/Qa-1-specific T cells can be strongly induced by messenger RNA vaccination and that they can mediate antigen-specific cytolysis in vivo. Our results demonstrate that noncanonical translation products can account for an important fraction of the T cell repertoire and add to a growing body of evidence that MHC-E-restricted T cells could have substantial therapeutic value.